Brexogen, a leading biotechnology company specialising in exosome-based therapeutics, has announced a technology transfe...
Novotech, a global full-service clinical Contract Research Organisation (CRO) that partners with biotech and small to mi...
South Korea-based OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics, has announced a global licensing...
The Australian Government is investing close to $20 million in funding for researchers to support groundbreaking nationa...
When almost half of clinical trial stakeholders describe their working relationships as "complicated," it’s a sign...
Kazia Therapeutics Limited , an oncology-focused drug development company, has announced the regulatory approval and lau...
National Taiwan University Hospital (NTUH) and AbbVie Biopharmaceuticals GmbH Taiwan Branch (AbbVie) have signed a coope...
Harvest Integrated Research Organization (HiRO), a boutique global clinical research organization (CRO) providing c...
Can you elaborate on Medidata’s growth strategy for the APAC region? What specific factors are driving the expansi...
The US Food and Drug Administration (FDA) has just approved the second drug in the past two years that’s currently...
The Life Sciences Industry: Pitfalls and the Impact of Failed Clinical Trials in 2024 The life sciences industry is at ...
Longstanding alliance between Evotec and CHDI to enable the development of therapeutics for Huntington’s disease...
To mark World Clinical Trials Day on May 20, Victorian Deputy Premier and Minister for Medical Research, Ben Carro...
Could you elaborate on some of the most prominent trends shaping the landscape of clinical trials in the Asia-Pacific re...
Making its triumphant return to the region this Summer, this meeting will bring together key players of the ADC lan...
Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-M...
What makes Uvax Bio’s technology different from other vaccine technologies? Recombinant protein vaccines ar...
Could you elaborate on the most prominent trends shaping the APAC clinical trials landscape? One of Lokavant’s ea...
